Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Puradelta Lestari Tbk. (DMAS) vs UBC Medical Indonesia Tbk. (LABS)

Puradelta Lestari Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Puradelta Lestari Tbk. dan UBC Medical Indonesia Tbk.: Puradelta Lestari Tbk. diperdagangkan di Rp137 (kapitalisasi pasar 6,6 T, volume 24 jam 40,24 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Puradelta Lestari Tbk. jauh lebih besar — sekitar 11,3× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Puradelta Lestari Tbk. lebih aktif diperdagangkan (40,24 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.

DMASLABS
Kapitalisasi Pasar
6,6 T584,6 M
Volume
40,24 jt817,3 rb
Lot
402,39 rb8,17 rb
Perputaran
5,52 M120,01 jt
Harga Rata-rata
137,3146,84
Nilai Transaksi
5,52 M120,01 jt
Harga Ekuilibrium Indikatif
137146
Volume Ekuilibrium Indikatif
9,27 rb59

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

DMAS
Lihat detail
LABS
Lihat detail

Tentang Puradelta Lestari Tbk.

PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.

Selengkapnya di halaman DMAS

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS